Speaker(s): 

Emilie Detweiler PharmD, PGY1 resident, Geisinger - has nothing to disclose.

Evan Liddington PharmD, PGY1 resident, Geisinger - has nothing to disclose.

Miranda Woosman PharmD, PGY1 resident, Geisinger - has nothing to disclose.

Moderator(s): 

Christopher J DeFrancesco PharmD, Geisinger - has nothing to disclose.

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

1. Compare clindamycin and linezolid use in necrotizing infections
2. Discuss preferred antibiotic therapies for gram negative infections caused by beta lactamase producing organisms
3. Apply nuances of treating Stenotrophomonas maltophilia infections

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Christopher DeFrancesco PharmD, RPH, Anil Singh MD, Roop Parlapalli, MD, FHM, FACP, Mary Ellen Berry PA-C, and Carlena Miller CRNP have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPAA compliant. 

Commercial Support for this Session

None